Immune to Cancer: The CRI Blog
-
CRI Researcher Highlights New Technique to Aid Immunotherapy
Dr. Mohammad Rashidian’s nanobodies could help improve doctors’ decisions regarding immunotherapy.
-
Checkpoint Inhibitors Benefit Lung Cancer Patients in Clinical Trials
Patients with metastatic non-small cell lung cancer could soon have a new first-line immunotherapy treatment option.
-
Oncogene Initiates Cancer Development through Immune Checkpoints
CLIP investigator Dean W. Felsher, MD, PhD, published his findings in the journal Science.
-
Cancer Immunotherapy Reverses Alzheimer’s in Mice
A checkpoint inhibitor may offer hope for Alzheimer’s patients.
-
What Is an Oncogene? Immunologists Rethink a Fundamental Cancer Concept
Immunology is reshaping how oncologists think about cancer, and even basic principles—like oncogenes—are getting a significant makeover.
-
New Study: Vaccine Holds Promise in Treating Cervical Pre-Cancer
The vaccine could provide a new treatment option for patients with high-risk cervical pre-cancer.
-
New Study Suggests a Common Heart Medication Could Help Cancer Patients Live Longer
A new study published yesterday in the journal Cancer suggests that a common medication known as…
-
When Is a Spot Not a Spot?
A ten-year effort to optimize a ubiquitous laboratory assay finally pays off.
-
CRI’s Impact on Colorectal Cancer Immunotherapy
CRI scientists have contributed significantly to the immunological understanding and treatment of colorectal cancer.